BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, January 21, 2026
Home » Authors » Brady Huggett

Articles by Brady Huggett

GenStar, Vascular Genetics To Form Autus, Combine Focuses

Sep. 16, 2002
By Brady Huggett
Vascular Genetics Inc. and GenStar Therapeutics Corp. are merging to form Autus Genetics Corp., a company that will focus on the lead products of both of its parts. The merger was born out of a conversation between the two heads of the companies early this year. (BioWorld Today)
Read More

GenStar, Vascular Genetics To Form Autus, Combine Focuses

Sep. 16, 2002
By Brady Huggett
Vascular Genetics Inc. and GenStar Therapeutics Corp. are merging to form Autus Genetics Corp., a company that will focus on the lead products of both of its parts. The merger was born out of a conversation between the two heads of the companies early this year. (BioWorld Today)
Read More

IDEC Views Early IDEC-114 Data In Psoriasis, Drops Indication

Sep. 6, 2002
By Brady Huggett

IDEC Views Early IDEC-114 Data In Psoriasis, Drops Indication

Sep. 6, 2002
By Brady Huggett

Aventis Declines Option For Alliance On Indevus' Pagoclone

Sep. 3, 2002
By Brady Huggett

Aventis Declines Option For Alliance On Indevus' Pagoclone

Sep. 3, 2002
By Brady Huggett

Alliance Cuts Staff, Pressures Venture For Oxygent Funding

Aug. 30, 2002
By Brady Huggett
Alliance Pharmaceutical Corp. has spent more than $200 million developing its intravascular oxygen carrier, Oxygent. But now facing a revised development plan that it cannot afford, Alliance cut 40 percent of its work force and warned PFC Therapeutics LLC, the joint venture set up to commercialize the product, that if funds don't materialize, the Oxygent license agreement will be terminated and the joint venture dissolved. (Bioworld Today)
Read More

Alliance Cuts Staff, Pressures Venture For Oxygent Funding

Aug. 30, 2002
By Brady Huggett
Alliance Pharmaceutical Corp. has spent more than $200 million developing its intravascular oxygen carrier, Oxygent. But now facing a revised development plan that it cannot afford, Alliance cut 40 percent of its work force and warned PFC Therapeutics LLC, the joint venture set up to commercialize the product, that if funds don't materialize, the Oxygent license agreement will be terminated and the joint venture dissolved. (Bioworld Today)
Read More

FDA-Requested Report Examines Animal Biotechnology Concerns

Aug. 26, 2002
By Brady Huggett
In a report that was requested by the FDA to better arm itself for the upcoming animal biotechnology regulatory decisions it will surely face, the National Academies' National Research Council said the gravest concern associated with the merging of biotechnology and animals is environmental. (BioWorld Today)
Read More

FDA-Requested Report Examines Animal Biotechnology Concerns

Aug. 26, 2002
By Brady Huggett
In a report that was requested by the FDA to better arm itself for the upcoming animal biotechnology regulatory decisions it will surely face, the National Academies' National Research Council said the gravest concern associated with the merging of biotechnology and animals is environmental. (BioWorld Today)
Read More
Previous 1 2 … 52 53 54 55 56 57 58 59 60 … 74 75 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 21, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 21, 2026.
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Illustration of magnifying glass inspecting brain

    Neurotrimin unveiled as marker in intellectual disability

    BioWorld Science
    Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing